Find verified Dabrafenib API manufacturers, suppliers, and distributors across the globe. Explore companies that offer high-purity Dabrafenib for pharmaceutical use, along with product details, certifications, and reliable sourcing options. Compare prices, check availability, and connect directly with trusted suppliers for Dabrafenib API.
Alternate Names: Tafinlar, Dabrafenibum
CAS No: 1195765-45-7
PubChem CID: 44462760
Mol Formula: C23H20F3N5O2S2
Mol Weight: 519.6 g/mol
IUPAC Name: N-[3-[5-(2-aminopyrimidin-4-yl)-2-tert-butyl-1,3-thiazol-4-yl]-2-fluorophenyl]-2,6-difluorobenzenesulfonamide
Drug Class: Kinase inhibitors
Commercial / Development Status: Commercial
API Description: Dabrafenib is a kinase inhibitor used to treat cancers with a BRAF V600 mutation, including unresectable/metastatic melanoma, non-small cell lung cancer (NSCLC), anaplastic thyroid cancer, and solid tumors. Often paired with trametinib, it inhibits abnormal protein signaling, slowing cancer growth.
